McKesson welcomes Deborah Dunsire to its Board as an Independent Director

– USA, TX –  McKesson Corporation (NYSE: MCK) announced the election of Dr. Deborah Dunsire (MD) to its Board as an Independent Director effective June 3, 2024.

“We’re pleased to welcome Deborah to the McKesson board. She is a highly respected healthcare industry leader with a proven track record of leading large, complex organizations as both a CEO and a board member. Her unique perspective, clinical background, and expertise within the pharmaceutical and oncology arenas will add great value to McKesson and its purpose of Advancing Health Outcomes for All®,” said Board Chair, Don Knauss.

Dr. Deborah Dunsire will also join the Compensation and Talent Committee and Finance Committee.

Concurrently, the company announced that Linda Mantia will not be standing for re-election at the 2024 AGM.

About Dr. Deborah Dunsire

Dr. Deborah Dunsire joins the board with over 30 years of experience leading large, matrixed organizations in the biopharmaceutical, oncology, and other specialty industries. Most recently, she retired from her role as president and chief executive officer of H. Lundbeck A/S, a biopharmaceutical company specializing in developing and delivering transformative therapies for brain diseases. Before that, she held executive leadership roles for several pharmaceutical companies including XTuit Pharmaceuticals, FORUM Pharmaceuticals, Millennium: The Takeda Oncology Company, and Millennium Pharmaceuticals. Dr. Dunsire started her career as a primary care physician in Johannesburg, South Africa.

Dr. Deborah Dunsire currently serves on the boards of directors of Syros Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc. She received her medical degree from the University of Witwatersrand in Johannesburg, South Africa.

About McKesson Corporation

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable.

For more: https://www.mckesson.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.